| Drug General Information |
| Drug ID |
D0O6SI
|
| Former ID |
DNC003041
|
| Drug Name |
1,4-Butanediol
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C4H10O2
|
| Canonical SMILES |
C(CCO)CO
|
| InChI |
1S/C4H10O2/c5-3-1-2-4-6/h5-6H,1-4H2
|
| InChIKey |
WERYXYBDKMZEQL-UHFFFAOYSA-N
|
| CAS Number |
CAS 110-63-4
|
| PubChem Compound ID |
|
| PubChem Substance ID |
476590, 584198, 587704, 826407, 826408, 833916, 3132270, 5759543, 7886370, 8155604, 10317707, 10317714, 10503864, 12077028, 15194210, 17389457, 17435958, 24854421, 24861305, 24861306, 24861307, 24861310, 24861311, 24866368, 24872855, 24874546, 24886097, 24886229, 24886474, 24887581, 24889295, 24889502, 24889905, 24889911, 26703409, 26703656, 26750555, 32679244, 37626313, 38236237, 38646019, 39838688, 46506248, 48417245, 48422135, 48424398, 49703992, 49816801, 49854712, 56465060
|
| Target and Pathway |
| Target(s) |
Phospholipase A2, membrane associated |
Target Info |
Inhibitor |
[1]
|
|---|
|
BioCyc Pathway
|
Phospholipases
|
|
KEGG Pathway
|
Glycerophospholipid metabolism
|
|
Ether lipid metabolism
|
|
Arachidonic acid metabolism
|
|
Linoleic acid metabolism
|
|
alpha-Linolenic acid metabolism
|
|
Metabolic pathways
|
|
Ras signaling pathway
|
|
Vascular smooth muscle contraction
|
|
Pancreatic secretion
|
|
Fat digestion and absorption
|
|
Pathway Interaction Database
|
Glypican 1 network
|
|
Reactome
|
Acyl chain remodelling of PC
|
|
Acyl chain remodelling of PE
|
|
Acyl chain remodelling of PI
|
|
WikiPathways
|
Cardiac Hypertrophic Response
|
|
Glycerophospholipid biosynthesis
|
|
Glycerophospholipid Biosynthetic Pathway
|
|
Spinal Cord Injury
|
|
Eicosanoid Synthesis
|
|
MicroRNAs in cardiomyocyte hypertrophy
|
| References |
| REF 1 | Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo. Eur J Pharmacol. 2003 Jul 25;473(2-3):149-52. |
|---|
